Exploring the role of febuxostat’s drug target XOR in erectile dysfunction: insights from human genetics and rat models
BackgroundThe use of the uric acid-lowering drug Febuxostat (FB) has been associated with the risk of erectile dysfunction (ED) in men; however, findings from previous studies remain inconsistent. This study aimed to investigate the association between FB target genes and ED, as well as the underlyi...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-11-01
|
| Serie: | Frontiers in Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1674086/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|